BRIEF published on 10/04/2024 at 18:20, 1 month 18 days ago Funding Circle Plc Executes Share Buyback London Stock Exchange Share Buyback Market Regulation Funding Circle Shares Cancellation
PRESS RELEASE published on 10/04/2024 at 18:15, 1 month 18 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 150,000 ordinary shares at prices ranging from 129.50p to 134.00p on 4 Oct 2024, as part of its buy-back program Ordinary Shares Buy-back Program Purchase Cancellation Funding Circle Plc
BRIEF published on 10/04/2024 at 11:26, 1 month 18 days ago Chief Financial Officer of Funding Circle Disposes Shares London Stock Exchange CFO Regulatory Announcement Funding Circle Share Disposal
PRESS RELEASE published on 10/04/2024 at 11:21, 1 month 18 days ago Funding Circle Plc: DSH-Director/PDMR Shareholding Funding Circle Plc reports Chief Financial Officer's disposal of shares. Oliver White sells 129,870 ordinary shares on 2 Oct 2024. For more: ir@fundingcircle.com Chief Financial Officer London Stock Exchange Market Abuse Regulation Funding Circle Plc Share Disposal
BRIEF published on 10/04/2024 at 11:18, 1 month 18 days ago Funding Circle CFO Sells Shares on London Stock Exchange London Stock Exchange Market Regulation Funding Circle Share Disposal Oliver White
PRESS RELEASE published on 10/04/2024 at 11:13, 1 month 18 days ago Funding Circle Plc: DSH-Director/PDMR Shareholding Funding Circle Plc CFO Oliver White disposes shares. Funding Circle is UK's top SME lending platform, empowering small businesses to access funding Small Businesses Funding Circle Plc SME Lending Platform Share Disposal Oliver White
BRIEF published on 10/03/2024 at 18:20, 1 month 19 days ago Funding Circle Plc Announces Share Buyback Transaction London Stock Exchange Ordinary Shares Share Buyback Numis Securities Funding Circle
PRESS RELEASE published on 10/03/2024 at 18:15, 1 month 19 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 249,707 ordinary shares, with highest price at 134.00p and lowest at 130.50p London Stock Exchange Shares Cancellation Funding Circle Plc Buy-back
BRIEF published on 10/02/2024 at 18:19, 1 month 20 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Numis Securities Funding Circle
PRESS RELEASE published on 10/02/2024 at 18:14, 1 month 20 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces purchase of 200,472 own shares for cancellation at London Stock Exchange, with highest price of 137.00p and lowest of 132.50p London Stock Exchange Share Purchase Cancellation Funding Circle Plc Buy-back
Published on 11/22/2024 at 23:55, 6 hours 24 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 6 hours 49 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 7 hours 14 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 7 hours 49 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 12 hours 5 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 12 hours 26 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 13 hours 24 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 14 hours 19 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 12 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 12 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
